<DOC>
	<DOCNO>NCT01968967</DOCNO>
	<brief_summary>This study multicenter , randomize study subject high cholesterol receive highly effective statin assess efficacy , safety tolerability Bococizumab ( PF-04950615 ; RN316 ) low LDL-C .</brief_summary>
	<brief_title>Randomized Clinical Trial Bococizumab ( PF-04950615 ; RN316 ) Subjects With Hyperlipidemia Mixed Dyslipidemia Risk Cardiovascular Events</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Treated statin . Fasting LDLC &gt; 70 mg/dL triglyceride &lt; =400 mg/dL . High high risk incur cardiovascular event . Pregnant breastfeeding female . Cardiovascular cerebrovascular event procedure past 30 day . Congestive heart failure NYHA class IV . Poorly control hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>mixed dyslipidemia</keyword>
	<keyword>high risk cardiovascular event</keyword>
	<keyword>multiple cardiovascular disease risk factor</keyword>
</DOC>